Ouafae Karimi

456 total citations
11 papers, 232 citations indexed

About

Ouafae Karimi is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Ouafae Karimi has authored 11 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Ouafae Karimi's work include Inflammatory Bowel Disease (4 papers), Urinary Tract Infections Management (3 papers) and Reproductive tract infections research (3 papers). Ouafae Karimi is often cited by papers focused on Inflammatory Bowel Disease (4 papers), Urinary Tract Infections Management (3 papers) and Reproductive tract infections research (3 papers). Ouafae Karimi collaborates with scholars based in Netherlands, United States and Germany. Ouafae Karimi's co-authors include A. S. Peña, Sander Ouburg, Adriaan A. van Bodegraven, Servaas A. Morré, Martijn T. Wijburg, Mike P. Wattjes, Bob W. van Oosten, Jean‐Luc Murk, Joep Killestein and Henry J.C. de Vries and has published in prestigious journals such as PLoS ONE, Inflammatory Bowel Diseases and Journal of Neurology.

In The Last Decade

Ouafae Karimi

11 papers receiving 224 citations

Peers

Ouafae Karimi
Jun Ren China
Elizabeth Barker United States
Longhuan Ma United States
M. R. Fairfax United States
Csaba Jeney Hungary
Jun Ren China
Ouafae Karimi
Citations per year, relative to Ouafae Karimi Ouafae Karimi (= 1×) peers Jun Ren

Countries citing papers authored by Ouafae Karimi

Since Specialization
Citations

This map shows the geographic impact of Ouafae Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ouafae Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ouafae Karimi more than expected).

Fields of papers citing papers by Ouafae Karimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ouafae Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ouafae Karimi. The network helps show where Ouafae Karimi may publish in the future.

Co-authorship network of co-authors of Ouafae Karimi

This figure shows the co-authorship network connecting the top 25 collaborators of Ouafae Karimi. A scholar is included among the top collaborators of Ouafae Karimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ouafae Karimi. Ouafae Karimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Verweij, Stephan P., Ouafae Karimi, Joseph M. Lyons, et al.. (2015). TLR2,TLR4andTLR9genotypes and haplotypes in the susceptibility to and clinical course ofChlamydia trachomatisinfections in Dutch women. Pathogens and Disease. 74(1). ftv107–ftv107. 16 indexed citations
2.
Wijburg, Martijn T., Bob W. van Oosten, Jean‐Luc Murk, et al.. (2014). Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature. Journal of Neurology. 262(1). 65–73. 39 indexed citations
3.
Jiang, Janina, Ouafae Karimi, Sander Ouburg, et al.. (2012). Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection. PLoS ONE. 7(11). e47487–e47487. 27 indexed citations
4.
Shrestha, Umid Kumar, Ouafae Karimi, Bart J. A. Crusius, et al.. (2009). Distribution of peroxisome proliferator–activated receptor–gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 16(2). 312–319. 18 indexed citations
5.
Karimi, Ouafae, et al.. (2009). Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunology & Medical Microbiology. 55(2). 140–153. 31 indexed citations
6.
Peña, A. S., Ouafae Karimi, & J. Bart A. Crusius. (2009). A new avenue to investigate: the autophagic process. From Crohn's disease to Chlamydia.. PubMed. 45 Suppl B. 113–7. 3 indexed citations
7.
Karimi, Ouafae, et al.. (2009). TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women.. PubMed. 45 Suppl B. 67–74. 26 indexed citations
8.
Karimi, Ouafae & A. S. Peña. (2008). Indications and Challenges of Probiotics, Prebiotics, and Synbiotics in the Management of Arthralgias and Spondyloarthropathies in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 42(Supplement 3). S136–S141. 14 indexed citations
9.
Karimi, Ouafae & A. S. Peña. (2005). Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease: Prospective randomized trials are necessary. Revista Española de Enfermedades Digestivas. 97(8). 570–4. 10 indexed citations
10.
Karimi, Ouafae, A. S. Peña, & Adriaan A. van Bodegraven. (2005). Probiotics (VSL#3) in arthralgia in patients with ulcerativecolitis and Crohn's disease: A pilot study. Drugs of today. 41(7). 453–453. 27 indexed citations
11.
Karimi, Ouafae & A. S. Peña. (2003). Probiotics: Isolated bacteria strain or mixtures of differentstrains?. Drugs of today. 39(8). 565–565. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026